Vanguard Group’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Vanguard Group’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,693	Closed	-$21.3K	–	4338
2025 Q1	$21.3K	Hold	5,693	–	–	﹤0.01%	4242
2024 Q4	$49.2K	Sell	5,693 -374	-6%	-$3.55K	﹤0.01%	4215
2024 Q3	$73.2K	Hold	6,067	–	–	﹤0.01%	4221
2024 Q2	$242K	Buy	6,067 +316	+5%	+$20.8K	﹤0.01%	4138
2024 Q1	$442K	Buy	5,751 +101	+2%	+$9.58K	﹤0.01%	4048
2023 Q4	$646K	Buy	5,650 +256	+5%	+$21.9K	﹤0.01%	3958
2023 Q3	$583K	Buy	+5,394	New	+$813K	﹤0.01%	4012

Other funds holding XAGE

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $915M AUM 19.16% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Vanguard Group's XAGE Position: Q2 2025 in Review

Vanguard Group sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2025, closing a stake of 5,693 shares — an estimated $21.3K sold.

Vanguard Group first reported a position in XAGE in Q3 2023 and held it in 7 quarters. The position peaked at $646K in Q4 2023. 11 funds tracked by Wall St. Rank hold XAGE as of Q2 2025.

Vanguard Group reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Vanguard Group sold 5,693 Longevity Health Holdings, Inc. Common Stock shares in Q2 2025, an estimated $21.3K.
Vanguard Group first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2023 and held it in 7 quarters.
Vanguard Group's Longevity Health Holdings, Inc. Common Stock position peaked at $646K in Q4 2023.
11 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2025.

Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.